NICOTANAMIDE PHOSPHORIBOSYLTRANSFERASE INHIBITORS AND METHODS FOR USE OF THE SAME
standard
posted on 2024-01-12, 18:34 authored by Tom DriverTom Driver, Roberto Machado, Naijing Su, Xinyu Guan, Wrickban Mazumdar, Kiira Ratia, Jason Hickok, Angelia LockettUnited States Patent
Patent No.: US 11,584,766 B2
https://patentimages.storage.googleapis.com/57/b3/4e/37d299a2ca4138/US11584766B2.pdf
Funding
"Evaluation and Optimization of the Toxicity and Metabolism of NAMPT Inhibitors to Identify a Novel Therapeutic for the Treatment of Proliferative Diseases | Funder: Discovery Partners Institute
Developing of NAMPT Inhibitors to Treat Pulmonary Arterial Hypertension | Funder: National Institutes of Health (National Heart, Lung, and Blood Institute) | Grant ID: HHSN268201700006C
Development of a Novel Therapy to Reverse Pulmonary remodeling in PAH | Funder: National Institutes of Health | Grant ID: R41 HL158407
History
Citation
Driver, Tom G., Roberto F. Machado, S. U. Najing, G. U. A. N. Xinyu, Wrickban Mazumdar, Kira Ratia, Jason Ralph Hickok, and Angelia Denise Lockett. "Nicotinamide phosphoribosyltransferase inhibitors and methods for use of the same." U.S. Patent 11,584,766, issued February 21, 2023.Usage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC